Abstract
Introduction
Candida species especially Candida albicans (C. albicans) are the composition of oral commensal flora, which can be isolated in the healthy oral cavities with different frequency (Cannon et al., 1995; Kleinegger et al., 1996; Qi et al., 2005) . At the same time, C. albicans is one of the most pervasive opportunistic pathogens, which can cause endogenous infection from superficial to seriously deep-seated mycoses under the altered host conditions, such as the malignant cancer patients (Brawner and Cutler, 1989; McCullough et al., 1996) . Anticancer treatment including chemotherapy or/and radiotherapy is still associated with several side effects. Among them, oral candidiasis is one major source of illness, although strict oral hygienic care has been undertaken by using anti-fungal reagents to prevent them (Wingard, 1994) . Oral candidiasis is often accompanied by pain, loss of taste, reduction in intake, and weight loss, thereby resulting in treatment delays and necessitating dose reduction (Mead, 2002) . Furthermore some studies have shown its potential importance in the development of systemic candidiasis which would be vital for these patients (Rodu et al., 1984; Kontoyiannis and Lewis, 2002) .
The main limitation of previous studies about oral Candida is the fact that only single isolates are elected from each patient for each episode. In fact there is heterogeneity among the oral Candida population (all the Candida colonies isolated from the same host) in phenotypic and genotypic aspects (Wimpenny et al., 2000; Stewart and Franklin, 2008) . For example, one research showed that up to 32 fold differences in fluconazole minimal inhibitory concentrations (MICs) were detected within isolates recovered at the same AIDS patient and episode (Lopez-Ribot et al., 1999) .
Since there is great heterogeneity among the individuals of the oral Candida population, it is reasonable to believe that this randomly selected single isolate cannot represent the whole view of the oral Candida population. Until now, the heterogeneity in the oral C. albicans population across China is still unknown, and many studies of genotype variation and antifungal resistance among isolates from AIDS patients have shown mixed results (Takasuka et al., 1998; Metzgar et al., 1998; Lopez-Ribot et al., 1999) .
This research may help us to understand the antifungal drug susceptibility and genotypic characteristics of oral Candida isolated from cancer patients in China, and would assist in getting the accurate susceptibility test in clinical practice.
Material and methods

Patients selection
Fifty-two cancer patients from two affiliated teaching hospitals and a cancer hospital of Shandong University Medical School were selected for this study and sampled for oral Candida carriage, including 6 patients with hematological malignancies, and 46 with solid tumors. The patients' ages ranged from 21 to 76 years old, averaging 49.8 years. There were 31 male patients and 21 female patients. The inclusion criteria for the study were previous diagnoses of advanced cancer for more than 1 year and treatment by chemotherapy. The exclusion criteria for this study were significant physical defects, denture wearers, uncontrolled diabetes mellitus, systemic antifungal medication or steroids within the recent 2 weeks. The patients with head and neck cancer receiving radiation therapy were excluded. This study was approved by the Ethics Committee of Shandong University (No. 2008-03) and Northeastern University MA US IRB (No. 09-01-02).
Sampling preparation
All patients received regular oral hygiene care including 0.2% chlorhexidine daily. Patients were examined by two physicians, according to the guidelines of oral candidiasis diagnostic standards, for evidence of oral candidiasis (Kleinegger et al., 1996) . They were sampled with specimens obtained 8 hours following regular oral hygiene care. The specimens were collected by passing a sterile swab across the inner cheek mucosal surface five times. The procedure was repeated three times in total within a half-hour interval. Swabs were transferred to a sterile test tube containing 500 µL sterile phosphate buffered saline (PBS). The tubes containing the swabs were vortexed vigorously for 30 seconds to suspend the samples. After 30 seconds, the swabs were removed, the samples were sedimented by centrifugation and concentrated by resuspending in 50 µL PBS. This suspension was spread plated on CHROMagar Candida TM differential medium, and incubated for 24-48 hours (Worthington and Clarkson, 2002) . Colonies were identified as Candida by CHROMagar based on color change and colony morphology of this propriety selective and differential medium (Tamura et al., 2001) . Candida strains were confirmed by API20C (BioMerieux France) based on carbon source utilization and other differential biochemical assays according to the manufacturer's directions (Xu et al., 2002) . C. albicans species were additionally confirmed by observing germ tube formation induced by serum via microscopy (Mackenzie, 1962) . If multiple Candida colonies were present, all of the isolates were subculture and chosen for further analysis.
Antifungal susceptibility test
The 10 mg⋅mL -1 stock solution of amphotericin B (AMB) (Fisher Scientific, USA) and chlorhexidine (CHX) (Sigma-Aldrich, USA) were prepared in dimethyl sulfoxide. The MIC of clinical isolates was determined by broth microdilution based on the CLSI M27-A2 guidelines (McArthur, 2006 
Genotypic determinations
Extraction of C. albicans DNA, 1-2 monocolonies from the YPD agar plates was suspended in 200 µL of TE buffer in a microcentrifuge tube. DNA extraction was carried out using Promega Wizard DNA Extacyion Kit (Promega, USA). Nucleic acid pellet was obtained, washed with ice-cold 70% ethanol, dried, and resuspended in sterile TE buffer at a concentration of 5 µg⋅mL -1 . Genotypic was determined using randomly amplified polymorphic DNA-PCR (RAPD) analysis. Two primers RSD6 (5'-GCG ATC CCC A-3') and RSD12 (5'-GCA TAT CAA TAA GCG CAG GAA AAG-3') for RAPD were those described by Fell and Akopyanz (Akopyanz et al., 1992; Fell, 1993 The amplification products were characterized by electrophoresis on 1.2% agarose gels in 1× TBE buffer at 50 V for 120 minutes, stained in a solution of 0.5 µg⋅mL -1 of ethidium bromide, and then visualized by UV transillumination (Bio Rad, USA) (Waltimo et al., 2001) .
Results
Oral Candida carriage and antifungal susceptibility of the Candida isolates from cancer patients
Oral Candida strains were isolated from 28 of 52 patients and the frequency of oral Candida carriage was 53.8%. Among them, Candida glabrata (C. glabrata) alone was detected in 3 patients.
The fungal burden of the patients was determined using the numbers of yeast colonies on the identification medium of each sample (Rüchel et al., 2000) . All the patients were divided into two groups according to the fungal burden. The average number of yeast cfu of Group A (fungal burden more than 7) was 13.4±5.2 (n=12), significantly higher than that of Group B (fungal burden less than 5), i.e., 2.8±1.4 (n=16) (P<0.001) (table 1).
Heterogeneity of antifungal susceptibility and genotype among the isolates of oral C. albicans population
The two primers, RSD6 and RSD12, were successful in eliciting 17 (A1-A17) and 2 (B1-B2) genotypes, respectively from among the 205 isolates. RSD6 (A1-A17) and RSD12 (B1-B2) were combined to generate 21 genotypes. Multiple C. albicans strains isolated from most of the patients (8/12) of Group A belong to the same genotype. While for 3 patients, 2 genotypes coexist at the same C. albicans population. However the oral C. albicans population of patient A8 showed highly genotypic heterogeneity (Figure 1 ). Much fewer stains were isolated from Group B patients, and genotypic heterogeneity could be detected in the C. albicans population of 4 patients (B1, B6, B9 and B12).
The variation in fluconazole susceptibility and genotype of the C. albicans isolates from the patients of Group A were analyzed. Firstly, for the isolates from patient A8, great heterogeneity could be observed in both genotype and fluconazole susceptibility (Table 2) . Secondly, all the isolates from patients A12 and A3 were genotype A6B1 and A9B2 respectively, having the same level of MIC 90 but different MIC 50 for fluconazole (Table 3) . Thirdly, two genotypes coexist in the same patient C. albicans population, but all the isolates show the same susceptibility to fluconazole, whatever MIC 50 or MIC 90 (patients A1, A4 and A7). Lastly, multiple isolates from the same patient were of the same genotype, meanwhile showing the same level of fluconazole susceptibility (patients A5, A6, A10 and A11). The average number of yeast cfu of Group A was 13.4±5.2 (n=12), significantly higher than that of Group B 2.8±1.4 (n=16). Most of the Group A patients and all of the oral C. glabrata had the clinical evidence of oral candidiasis, indicating that high fungal burden and C. glabrata carriage may be interrelated with oral Candida infectious disease.
Oral Variation
C.albicans
Sun et al. http://www.ijos.org.cn Figure 1 RAPD fingerprints of C. albicans isolated from patient A8 obtained using primer RSD6
Five genotypes were elicited among the 10 strains isolated from patient A8. Please note that No.2, 3, 4, 5, 7 and 8 belong to the same genotype. The heterogeneity could be found in both genotype and fluconazole susceptibility for the isolates from patient A8. But most of strains (6/10) belonged to the same genotype (A9B2). Up to 32 fold differences in fluconazole, MIC 50 were detected within isolates recovered at the same patient and episode, which is consistent with the results of Lopez-Ribot.
Discussion
Oral candidiasis is a common side-effect of anticancer chemotherapy for malignant cancer patients (Clarkson et al., 2000; Worthington and Clarkson, 2002) . Our results however showed that the frequency of oral Candida carriage was 58% which was similar with the afore-reported frequency of healthy host. There were 19% (10/52) patients who had the clinical diagnosis of oral candidiasis. This frequency of oral yeast carriage and oral candidiasis varied according to different studies. The difference in sampling preparation and position, treatment conditions of the patients, and geographic area may contribute to the diversity of frequency (Rodu et al., 1984; da Costa et al., 2009) . More and more researches indicated that heterogeneity of phenotype and genotype among the population of microorganisms (Wimpenny et al., 2000; Kontoyiannis and Lewis, 2002) . It is believed that heterogeneity may play a role in determining the fitness of cell populations, and by producing variant subpopulation of different phenotypes, the cell population can be more suitable for persisting during harsh condition (Bishop et al., 2007; ) . This is important for the microorganism population which inhabit at a frequently changing environ-ment such as oral cavity (McArthur, 2006) . Thus the heterogeneity of phenotype and genotype in the oral yeast population should be reasonable. In this study, all the C. albicans colonies from the same patients were selected for heterogeneity study. We found that C. albicans isolates with different fluconazole MICs and genotypes could coexist in the same oral Candida population, which reinforces this hypothesis.
RAPD is an ideal method for analyzing the C. albicans genotype, greatly dependent on the choice of primers and the genomic locus selected. In this research we employed the primer RSD12 and RSD6 for they have been successfully subgrouping the yeast strains. Distinctively different from the other research using primer RSD12, RSD12 in our research only elicited 2 genotypes from among the 205 isolates. The C. albicans strains isolated from different geographic areas may contribute to this phenomenon (Tsang et al., 1995) .
From the results of genotypic determinations of Group A patients using RAPD analysis, the multiple colonies from the same patient generally belong to the similar genotype. Although there still had an exception such as strain A8, multiple genotypes with different MIC for fluconazole coexisted in the same population, and most of the strains (6/10) still belonged to the same genotype. Genotypic heterogeneity also could be detected in the population of some patients of Group B, although much fewer isolates from Group B patients. The results indicate that multiple isolates may be reproduced by one or two colonies. The genotypic heterogeneity may be ascribed to the interference of transient strains (Metzgar et al., 1998) . But the isolates with the same genotype show different antifungal susceptibility, which reminds us that this hypothesis needs to be further studied.
Resistance of C. albicans isolates to azoles is the most prevalent type of antifungal resistance, also showing great heterogeneity (Lopez-Ribot et al., 1999; Kontoyiannis and Lewis, 2002) . Fluconazole resistance in C.albicans can be attributed to overexpression of the drug target (lanosterol demethylase), mutations in the drug target, and most commonly for high-level resistance, overexpression of energy-dependent drug efflux pumps. Our research indicated that although some C. albicans population showed great heterogeneity in fluconazole susceptibility, analyzing both MIC 50 and MIC 90 can be helpful for grasping the whole view of the population. For example, all the isolates from patient A12 showed very high MIC 90 despite a great diversity in MIC 50 . This fact remind us that comprehensive consideration of MIC 50 and MIC 90 for azole antifungal drugs susceptibility or some measurement such as agar dilution screening technique (Patterson et al., 1996a; Patterson et al., 1996b) may be useful to provide a more comprehensive assessment and avoid the aberration in clinical practice.
